Beasley Allen in the News

Articles 501 to 510 of 684 .

Prescription for Trouble

| November 14, 2004
When the pharmaceutical giant Merck pulled its blockbuster pain medication Vioxx off the market in late September, it became the largest prescription drug recall in history.

Despite Warnings, Drug Giant took long path to Vioxx Recall

The New York Times | November 14, 2004
In May 2000, executives at Merck, the pharmaceutical giant under siege for its handling of the multi-billion-dollar drug Vioxx, made a fateful decision.

Former Pell City Resident to Appear on '60 Minutes'

The Daily Home | November 13, 2004
Some of Pell City's citizens may recognize a familiar face if they turn on 60 minutes Sunday night.

Lawyers prepare for litigation against Merck over Vioxx

| November 12, 2004
Representatives of both the drugmaker Merck and the FDA will be on Capitol Hill next week to answer safety questions about Merck's drug Vioxx.

Lawyers bone up on Vioxx Liability

| November 10, 2004
On the September morning Merck pulled its blockbuster pain medicine Vioxx from the market, a group of lawyers was busy taking a deposition from the drug maker's former chief medical officer.

Courses Share info On Basics of Billion Dollar Tort

The New Jersey Star-Ledger | November 10, 2004
On the September morning Merck pulled its blockbuster pain medicine Vioxx from the market, a group of lawyers was busy taking deposition from the drug maker's former chief medical officer.

Lawyers meet to discuss scope of Vioxx Litigation.

| November 9, 2004
Lawyers meeting to discuss Vioxx litigation say pending lawsuits will show that Merck & Co. Inc. was aware of the arthritis drug's risks before it was taken off the market.

Lawyers Meet to Discuss Scope of Vioxx Litigation

Reuters | November 9, 2004
Lawyers meeting on Tuesday to discuss Vioxx litigation say pending lawsuits will show that Merck & Co, Inc. (MRK.N) was aware of the arthritis drug's risks before it was taken off the market.

Vioxx shockwaves rock Merck

The Trentonian | November 7, 2004
Merck & Co.'s Pandora's box has been opened wide, affecting much more than just the 20 million users of Vioxx.

Liablity could Reach $17.6B

| November 5, 2004
Already wounded by the withdrawal of its Vioxx pain reliever from the market, Merck & Co. must now contend with hundreds of lawsuits over the drug's side effects.